New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who ...
Researchers sought to determine whether subcutaneous isatuximab would be an effective treatment for patients with RRMM.
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
Sometimes, the best way to achieve a big outcome is to start small. That principle is at the center of new work from a ...
Subcutaneous vedolizumab dose intensification restored steroid-free clinical response in approximately one-third of patients with IBD.